Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Chart Industries $1.1 billion common and depositary share offerings
The proceeds will be used to fund in part the acquisition of Howden
Illumina $1 billion notes offering
The investment-grade notes are due 2027
NextEra Energy Partners $500 million convertible senior notes offering
The 2.5% convertible senior notes are due 2026
Prometheus Biosciences $500 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Amgen $28.5 billion Horizon Therapeutics acquisition financing
We advised the lender parties on the financing
Mongolian Mining cash tender offer
The tender offer is for the outstanding 9.25% guaranteed senior notes due 2024
Trimble €1.88 billion Transporeon acquisition financing
We are advising the lead arranger and bookrunner on the acquisition financing
Uniti Group $300 million convertible senior notes and capped call transactions
We advised Uniti on the transactions
Weber take-private acquisition by BDT Capital Partners and related financings
We are advising Weber on the transaction
Axon $690 million convertible senior notes offering
The 0.50% convertible notes are due 2027